{"id":9562,"date":"2022-11-06T18:34:19","date_gmt":"2022-11-06T18:34:19","guid":{"rendered":"https:\/\/dailytalks.org\/?p=9562"},"modified":"2022-11-06T18:34:19","modified_gmt":"2022-11-06T18:34:19","slug":"co-led-by-legend-capital-top-gene-delivery-enterprise-vectorbuilder-secures-cny410mn-in-series-c-round","status":"publish","type":"post","link":"https:\/\/dailytalks.org\/?p=9562","title":{"rendered":"Co-Led by Legend Capital, Top Gene Delivery Enterprise VectorBuilder Secures CNY410mn in Series C Round"},"content":{"rendered":"<p>HONG KONG, Oct 20, 2022 &#8211; (ACN Newswire) &#8211;  VectorBuilder Biotechnology (Guangzhou) Co., Ltd. (hereinafter referred to as &#8220;VectorBuilder&#8221;), a top gene delivery enterprise, recently announced the completion of its Series C round with CNY410 million, co-led by Legend Capital. The proceeds will facilitate VectorBuilder in continuously promoting the upgrading and capacity expansion of the gene delivery R&#038;D and production technology platform&#8230;<br \/><a href=\"https:\/\/en.acnnewswire.com\/press-release\/english\/78691\/\" class=\"button purchase\" rel=\"nofollow noopener\" target=\"_blank\">Read More<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>HONG KONG, Oct 20, 2022 &#8211; (ACN Newswire) &#8211; VectorBuilder Biotechnology (Guangzhou) Co., Ltd. (hereinafter<\/p>\n","protected":false},"author":1,"featured_media":9563,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[35],"tags":[],"class_list":["post-9562","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-tech"],"featured_image_urls":{"full":["https:\/\/dailytalks.org\/wp-content\/uploads\/2022\/11\/9562-co-led-by-legend-capital-top-gene-delivery-enterprise-vectorbuilder-secures-cny410mn-in-series-c-round.jpg",220,68,false],"thumbnail":["https:\/\/dailytalks.org\/wp-content\/uploads\/2022\/11\/9562-co-led-by-legend-capital-top-gene-delivery-enterprise-vectorbuilder-secures-cny410mn-in-series-c-round-150x68.jpg",150,68,true],"medium":["https:\/\/dailytalks.org\/wp-content\/uploads\/2022\/11\/9562-co-led-by-legend-capital-top-gene-delivery-enterprise-vectorbuilder-secures-cny410mn-in-series-c-round.jpg",220,68,false],"medium_large":["https:\/\/dailytalks.org\/wp-content\/uploads\/2022\/11\/9562-co-led-by-legend-capital-top-gene-delivery-enterprise-vectorbuilder-secures-cny410mn-in-series-c-round.jpg",220,68,false],"large":["https:\/\/dailytalks.org\/wp-content\/uploads\/2022\/11\/9562-co-led-by-legend-capital-top-gene-delivery-enterprise-vectorbuilder-secures-cny410mn-in-series-c-round.jpg",220,68,false],"1536x1536":["https:\/\/dailytalks.org\/wp-content\/uploads\/2022\/11\/9562-co-led-by-legend-capital-top-gene-delivery-enterprise-vectorbuilder-secures-cny410mn-in-series-c-round.jpg",220,68,false],"2048x2048":["https:\/\/dailytalks.org\/wp-content\/uploads\/2022\/11\/9562-co-led-by-legend-capital-top-gene-delivery-enterprise-vectorbuilder-secures-cny410mn-in-series-c-round.jpg",220,68,false],"chromenews-featured":["https:\/\/dailytalks.org\/wp-content\/uploads\/2022\/11\/9562-co-led-by-legend-capital-top-gene-delivery-enterprise-vectorbuilder-secures-cny410mn-in-series-c-round.jpg",220,68,false],"chromenews-large":["https:\/\/dailytalks.org\/wp-content\/uploads\/2022\/11\/9562-co-led-by-legend-capital-top-gene-delivery-enterprise-vectorbuilder-secures-cny410mn-in-series-c-round.jpg",220,68,false],"chromenews-medium":["https:\/\/dailytalks.org\/wp-content\/uploads\/2022\/11\/9562-co-led-by-legend-capital-top-gene-delivery-enterprise-vectorbuilder-secures-cny410mn-in-series-c-round.jpg",220,68,false]},"author_info":{"display_name":"Jonathan Jeriah","author_link":"https:\/\/dailytalks.org\/?author=1"},"category_info":"<a href=\"https:\/\/dailytalks.org\/?cat=35\" rel=\"category\">Tech<\/a>","tag_info":"Tech","comment_count":"0","_links":{"self":[{"href":"https:\/\/dailytalks.org\/index.php?rest_route=\/wp\/v2\/posts\/9562","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dailytalks.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dailytalks.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dailytalks.org\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/dailytalks.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=9562"}],"version-history":[{"count":0,"href":"https:\/\/dailytalks.org\/index.php?rest_route=\/wp\/v2\/posts\/9562\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/dailytalks.org\/index.php?rest_route=\/wp\/v2\/media\/9563"}],"wp:attachment":[{"href":"https:\/\/dailytalks.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=9562"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dailytalks.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=9562"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dailytalks.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=9562"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}